Our results demonstrate that the 18F‐PI‐2620 tracer exhibits high binding characteristics and detects 4R‐tau pathology in the basal ganglia with notable sensitivity and specificity, as was evident from comparing 4RT against both AD and controls. Here, MAPT is linked to Alzheimer disease.